NCT03139084View on ClinicalTrials.gov

Efficacy and Safety of Upfront Combination of ΒΟsentan and ΤΑdalafil in Pulmonary Arterial Hypertension

WithdrawnOBSERVATIONAL
0
Timeline

Start Date

December 1, 2017

Primary Completion Date

December 1, 2019

Study Completion Date

December 1, 2019

Conditions
Pulmonary Hypertension
Sponsors
All Listed Sponsors
lead

Elpen Pharmaceutical Co. Inc.

INDUSTRY